Antiretrovirals for low income countries: an analysis of the commercial viability of a highly competitive market

por Nakakeeto, Olive N, Elliott, Brian V
Publicado 2013

A RETROSPECTIVE SAFETY ANALYSIS OF INTUBATIONS ON PATIENTS WITH COVID-19 BY RESIDENT VERSUS ATTENDING PHYSICIANS

por ELLIOTT, BRIAN, P DOLLIN, YONATAN, YOUNG, HOLLIS, MARKERT, RONALD, T KOROSCIL, MATTHEW
Publicado 2022

Implementation and Evaluation of a Longitudinal Flipped-Classroom Point-of-Care Ultrasound Curriculum at an Internal Medicine Residency Program

por Elliott, Brian P, Berglund, Andrew J, Markert, Ronald J, Burtson, Kathryn M
Publicado 2023

Cost-consequence model comparing eltrombopag versus romiplostim for adult patients with chronic immune thrombocytopenia

por Tremblay, Gabriel, Dolph, Mike, Bhor, Menaka, Said, Qayyim, Elliott, Brian, Briggs, Andrew
Publicado 2018

Cost-consequence model comparing eltrombopag and romiplostim in pediatric patients with chronic immune thrombocytopenia

por Tremblay, Gabriel, Dolph, Mike, Bhor, Menaka, Said, Qayyim, Roy, Anuja, Elliott, Brian, Briggs, Andrew
Publicado 2018

Systematic review of outcomes and patient heterogeneity in relapsed or refractory diffuse large B-cell lymphoma

por Miller, Sally D, Lozano-Ortega, Greta, Mutebi, Alex, Briggs, Owanate, Sail, Kavita, Elliott, Brian, Kalsekar, Anupama
Publicado 2022

A retrospective cohort study assessing acute kidney injury and renal recovery among septic patients empirically treated with vancomycin piperacillin–tazobactam versus vancomycin ce...

por Elliott, Brian Pacca, Tang, Michael M, Madden, Joshua Alexander, Markert, Ronald James, Burdette, Steven Dale, Pleiman, Craig Matthew, Speelmon, Emily Claire
Publicado 2021

Semimechanistic Physiologically‐Based Pharmacokinetic/Pharmacodynamic Model Informing Epcoritamab Dose Selection for Patients With B‐Cell Lymphomas

por Li, Tommy, Hiemstra, Ida H., Chiu, Christopher, Oliveri, Roberto S., Elliott, Brian, DeMarco, Dena, Salcedo, Theodora, Egerod, Frederikke Lihme, Sasser, Kate, Ahmadi, Tahamtan, Gupta, Manish
Publicado 2022

P1149: COMPARISON OF THE EFFICACY OF EPCORITAMAB VERSUS CHIMERIC ANTIGEN RECEPTOR THERAPIES, POLATUZUMAB-BASED REGIMENS, AND TAFASITAMAB-BASED REGIMENS

por Rosenthal, Allison, Jun, Monika, Munoz, Javier, Wang, Tongsheng, Mutebi, Alex, Wang, Anthony, Yang, Shibing, Osei-Bonsu, Kojo, Elliott, Brian, Kalsekar, Anupama, Rivas Navarro, Fernando, Ip, Andrew
Publicado 2023

Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell–Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial

por Thieblemont, Catherine, Phillips, Tycel, Ghesquieres, Herve, Cheah, Chan Y., Clausen, Michael Roost, Cunningham, David, Do, Young Rok, Feldman, Tatyana, Gasiorowski, Robin, Jurczak, Wojciech, Kim, Tae Min, Lewis, David John, van der Poel, Marjolein, Poon, Michelle Limei, Cota Stirner, Mariana, Kilavuz, Nurgul, Chiu, Christopher, Chen, Menghui, Sacchi, Mariana, Elliott, Brian, Ahmadi, Tahamtan, Hutchings, Martin, Lugtenburg, Pieternella J.
Publicado 2023